Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 7/20 | 0.45 |
| ▸ | GSK3A | P49840 | 6/20 | 0.45 |
| ▸ | DYRK1A | Q13627 | 10/20 | 0.42 |
| ▸ | WNT1 | P04628 | 6/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.41 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.41 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.41 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.41 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.41 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.41 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL26128579 | 1.00 | GSK3B (0.45) | GSK3BGSK3ADYRK1AWNT1KDR | |
| SCHEMBL26395004 | 0.94 | GSK3B (0.47) | GSK3BGSK3ADYRK1AWNT1 | |
| Trifluoroacetic Acid SCHEMBL26130936 | 0.87 | AAK1 (0.49) | GSK3BGSK3ADYRK1AWNT1KDR | |
| Trifluoroacetic Acid SCHEMBL31243719 | 0.87 | AAK1 (0.49) | GSK3BGSK3ADYRK1AWNT1KDR | |
| Trifluoroacetic Acid SCHEMBL31243397 | 0.86 | GSK3B (0.40) | GSK3BGSK3ADYRK1AKDR | |
| Trifluoroacetic Acid SCHEMBL26131410 | 0.86 | GSK3B (0.40) | GSK3BGSK3ADYRK1AKDR | |
| SCHEMBL26396281 | 0.86 | GSK3B (0.42) | GSK3BGSK3ADYRK1APRKAA1 | |
| SCHEMBL26396318 | 0.86 | DYRK1A (0.45) | GSK3BGSK3ADYRK1AWNT1 | |
| Trifluoroacetic Acid SCHEMBL31243436 | 0.85 | GSK3B (0.45) | GSK3BGSK3ADYRK1AWNT1KDR | |
| Trifluoroacetic Acid SCHEMBL26130606 | 0.85 | GSK3B (0.45) | GSK3BGSK3ADYRK1AWNT1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118974020-A | Substituted 3-aminoindazole derivatives as kinase inhibitors | 内尔维亚诺医疗科学公司 | 2024-11-15 | — | — | CN | disclosed |